Retinal involvement of coronavirus disease (COVID-19): A systematic review

نویسندگان

چکیده

COVID-19 has wide-ranging manifestations which involve various organs. Although is known to affect mainly the respiratory system, many patients suffered from ocular following SARS-CoV-2 infection, especially conjunctivitis. However, there was some evidence of broader involvement, could retinal layer. This review aims analyze possible explanation involvement in and whether comorbidities increase risk COVID-19. We conducted a systematic literature search during September 2020 using PUBMED database other additional sources (e.g., Google Scholar). There no year publication nor language restriction. Six papers are used this review: two studies reported lesions patients, one study detected RNA biopsies three proposed mechanisms Ocular structures express ACE-2, such as aqueous humor, pigmented epithelium, retina. supported by finding nucleic acid postmortem patients. Retinal includes hyperreflective retina lesions, subtle cotton wool spots, microhemorrhage. these findings do not necessarily indicate specificity involvement. Diabetes mellitus may be associated with disease severity Some infection involves detection expression ACE-2 retina, role comorbidities.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Review of Coronavirus Disease-2019 (COVID-19)

There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower ...

متن کامل

A Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)

The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...

متن کامل

Obesity and Coronavirus Disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection that was first reported on December 31, 2019 in China . This disease behaves variously: from asymptomatic infection to influenza-like symptoms and severe acute respiratory distress syndrome (ARDS) . In the recent months, COVID-19 has infected millions and killed hundre...

متن کامل

Exercise Considerations during Coronavirus Disease 2019 (COVID-19) Outbreak: A Narrative Review

The widespread outbreak of coronavirus (COVID-19) worldwide has raised concerns about physical activity and exercise. A review of research on physical training and viral infections shows that regular, moderate-intensity aerobic exercise (65-80% VO2max) increases antibody titers, lymphocyte proliferation, gamma interferon, immunoglobulin M, G, and natural killer cells production. It modulates th...

متن کامل

Understanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Review Study

Since December 2019, a new coronavirus, called the 2019-novel coronavirus (2019-nCoV), triggers pneumonia outbreak from Wuhan (Huanan seafood market) across China, which now poses major health threats to public health. The Corona Virus Disease-2019 (COVID-19) epidemic by 2019-nCoV is spreading worldwide, and by March 1, 2020, 67 countries, including Iran, have been affected. According to worldw...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Community Empowerment for Health

سال: 2021

ISSN: ['2654-8283', '2655-0164']

DOI: https://doi.org/10.22146/jcoemph.61560